A doctor vaccinates an employee with the Pfizer BioNTech vaccine at the vaccination center of CHEMPARK operator CURRENTA in Leverkusen, western Germany, on June 22, 2021, amid the ongoing coronavirus (Covid-19) pandemic. Since June the prioritisation for vaccination against Covid-19 has been lifted nationwide. Now the company doctors at the sites in the CHEMPARKS of Leverkusen, Krefeld-Uerdingen and Dormagen can vaccinate the approx. 35000 employees. It is a joint initiative of the companies located at the CHEMPARK sites, which include CHEMPARK operator CURRENTA, LANXESS, Bayer and Covestro.  / AFP / Ina FASSBENDER
A doctor vaccinates an employee with the Pfizer BioNTech vaccine at the vaccination centre of CHEMPARK operator CURRENTA in Leverkusen, western Germany, on June 22 2021. AFP

Share of Covid-19 cases caused by Delta variant more than double in Germany




View from London

Your weekly update from the UK and Europe

      By signing up, I agree to The National's privacy policy
      View from London